Kura Oncology Logo
Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO-539
June 24, 2021 08:30 ET | Kura Oncology, Inc.
– Phase 1b expansion cohorts designed to enable refinement of recommended Phase 2 dose – – At least 12 patients to be enrolled in each of two Phase 1b expansion cohorts: a 200 mg dose cohort and a...
Kura Oncology Logo
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
November 11, 2015 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...